COVID-19-neutralizing antibodies predict disease severity and survival

Wilfredo F. García-Beltrán(Massachusetts General Hospital), Evan C. Lam(Ragon Institute of MGH, MIT and Harvard), Michael G. Astudillo(Massachusetts General Hospital), Diane Yang(Massachusetts General Hospital), Tyler E. Miller(Massachusetts General Hospital), Jared Feldman(Ragon Institute of MGH, MIT and Harvard), Blake M. Hauser(Ragon Institute of MGH, MIT and Harvard), Timothy M. Caradonna(Ragon Institute of MGH, MIT and Harvard), Kiera Clayton(Ragon Institute of MGH, MIT and Harvard), Adam D. Nitido(Ragon Institute of MGH, MIT and Harvard), Mandakolathur R. Murali(Massachusetts General Hospital), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Richelle C. Charles(Massachusetts General Hospital), Anand S. Dighe(Massachusetts General Hospital), John A. Branda(Massachusetts General Hospital), Jochen K. Lennerz(Massachusetts General Hospital), Daniel Lingwood(Ragon Institute of MGH, MIT and Harvard), Aaron G. Schmidt(Ragon Institute of MGH, MIT and Harvard), A. John Iafrate(Massachusetts General Hospital), Alejandro B. Balazs(Ragon Institute of MGH, MIT and Harvard)
Cell
December 16, 2020
10.1016/j.cell.2020.12.015
Cited by 792Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis